Search for: "ACTAVIS"
Results 901 - 920
of 1,010
Sorted by Relevance
|
Sort by Date
6 Apr 2011, 12:18 am
Laboratorios Rubió (EPLAW) Gemzar (Gemcitabine) – US: ITC: Target date of 23 July 2012 set in Certain Gemcitabine (ITC 337 Law Blog) Intuniv (Guanfacine) – US: Shire files patent infringement complaint based on Mylan’s ANDA filing (Patent Docs) Isentress (Raltegravir) – India: Cipla files for compulsory license against Merck’s Isentress (Spicy IP) Losartan, HCTZ – France: Cour d’appel confirms combination products infringe mono-SPCs and sets… [read post]
26 Jun 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
6 Jun 2017, 1:00 am
The District Court first considered relevant decisions from the German courts (LG Hamburg 2 April 2015, Warner-Lambert v A Pharma; OLG Düsseldorf 1 December 2015, KKH v Pfizer), and UK court (England and Wales Court of Appeal 28 May 2015 and 13 October 2016, Warner-Lambert v Actavis). [read post]
3 Dec 2018, 1:00 am
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor, heard 19-20 Nov 2018. [read post]
9 Dec 2009, 11:29 am
Actavis Mid Atlantic LLC, ___ F. [read post]
10 Nov 2010, 1:11 am
Roche (Filewrapper) (Property, intangible) US: Senator Sanders letter to FDA: U.S. needs an ethical pathway for biological products (KEI) (FDA Law Blog) US: Daiichi Sankyo seeks review and correction of patent term adjustment calculation for patent relating to ‘nucleoside and oligonucleotide analogues’ (Patent Docs) US: CAFC in Abraxis v Navinta: remembering Stanford/Roche (IPBiz) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaint against Teva in… [read post]
19 Jun 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
13 Jul 2011, 3:04 am
Doubtful (FDA Law Blog) US: Joint citizen petition asks FDA for clarity on off-label use manufacturer-communications (FDA Law Blog) Products Allegra (Fexofenadine) – US: Sanofi settles with Actavis in Allegra suit (Patent Docs) Aloxi (Palonosetron) – US: Roche sues Teva, Sandoz, Dr Reddy over generic Aloxi (GenericsWeb) Amrix (Cyclobenzaprine) – US: CAFC changes course, denies stay of injunction of Mylan’s generic Amrix sales: In re Cyclobenzaprine… [read post]
9 Nov 2016, 4:53 am
Similarly, in Warner-Lambert v Actavis [2016], the Court of Appeal recently stated, within the context of an allegation of insufficiency of a Swiss form second medical use claim, that plausibility is a “low threshold test” which “is not designed to prohibit patents for good faith predictions which have some, albeit manifestly incomplete basis”. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US:… [read post]
22 Dec 2010, 3:01 am
Actavis Elizabeth LLC et al (Patent Docs) Solodyn (Minocycline) – US: Patent infringement complaint filed following a Paragraph IV certification: Medicis Pharmaceutical Corp. v. [read post]
21 Dec 2018, 9:14 am
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor was heard on 19 November 2018. [read post]
25 Feb 2019, 1:00 am
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor, heard 19-20 Nov 2018. [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]
13 May 2010, 4:58 pm
Pharma Change ApS - Actavis A/S entered as independent party (EPLAW) Metvixia (Methyl aminolevulinate) - US: CAFC upholds patent term extensions in Levaquin and Metvixia cases: Ortho-McNeil and Daiichi Sankyo v. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) – US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) – US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) – US: Teva files amended complaint against Momenta/Sandoz to include infringement of three… [read post]
22 Mar 2016, 4:00 am
Although manufacturers are still fragmented, consolidations continue based on “better rationales” (given the standard merger rewards may not necessarily exist): including Pfizer/Hospira, Teva/Actavis and focused start-ups. [read post]
17 Jun 2013, 1:21 pm
Actavis (docket 12-416) was based far more on antitrust than patent law, and was at least a warning that settling lawsuits — at least in the drug industry — is a practice not necessarily free from risk. [read post]
27 Jul 2011, 1:01 am
(IPBiz) (Patently-O) (Patent Docs) (GenericsWeb) Copaxone (Glatiramer) – US: Mylan and Momenta challenge Teva patent on Copaxone (IPBiz) Gemzar (Gemcitabine) – US: Strides Arcolab announces US FDA approval for Gemcitabine for injections USP (GenericsWeb) Glybera (Alipogene tiparvovec) – EU: EMA continues to defer approval of first gene therapy application in Europe (Patent Docs) Jalyn (Dutasteride, Tamsulosin) – US: Watson files ANDA to market generic Jalyn, Glaxo responds… [read post]
3 Nov 2014, 11:10 am
Others include: Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) What is the next step? [read post]
